Please login to the form below

Not currently logged in
Email:
Password:

Otexla

This page shows the latest Otexla news and features for those working in and with pharma, biotech and healthcare.

FDA green light for Pfizer's eczema drug

FDA green light for Pfizer's eczema drug

Blockbuster-hopeful Eucrisa expected to launch early next year at $580 per 60mg tube

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Impetus Digital

Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...